1. Home
  2. ORIO vs ITRM Comparison

ORIO vs ITRM Comparison

Compare ORIO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIO

Orion Digital Corp. Common Shares

N/A

Current Price

$0.90

Market Cap

23.0M

Sector

N/A

ML Signal

N/A

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIO
ITRM
Founded
N/A
2015
Country
Canada
Ireland
Employees
188
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ORIO
ITRM
Price
$0.90
$0.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
46.7K
30.9M
Earning Date
03-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$74.52
N/A
Revenue Next Year
$5.07
$947.65
P/E Ratio
$4.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.03
52 Week High
$1.40
$1.16

Technical Indicators

Market Signals
Indicator
ORIO
ITRM
Relative Strength Index (RSI) 36.37 26.10
Support Level N/A N/A
Resistance Level $0.98 $0.39
Average True Range (ATR) 0.04 0.02
MACD -0.00 -0.01
Stochastic Oscillator 18.86 3.34

Price Performance

Historical Comparison
ORIO
ITRM

About ORIO Orion Digital Corp. Common Shares

Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: